US EditionRedcliffe Labs reports INR 419 crore revenue in FY25, expands diagnostic reach across tier 2 and smaller cities - Express Healthcare
Summary by Express Healthcare
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
Redcliffe Labs reports INR 419 crore revenue in FY25, expands diagnostic reach across tier 2 and smaller cities - Express Healthcare
Redcliffe Labs has reported a revenue of INR 419 crore in FY25, marking a 20 per cent increase from INR 350 crore in FY24. The company attributes this growth to its continued efforts in expanding diagnostic access across underserved regions of India, particularly Tier 2 cities and beyond. According to Redcliffe Labs, over 70 per cent of its diagnostic volumes now come from non-metro areas, reflecting a shift in healthcare access from urban centr…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
